Nvidia Total Cost of Revenue increased by 20.1% to $20.46B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.6%, from $17.39B to $20.46B. Over 4 years (FY 2022 to FY 2026), Total Cost of Revenue shows an upward trend with a 60.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.03B | $2.29B | $2.47B | $2.64B | $2.86B | $3.79B | $2.75B | $2.22B | $2.54B | $4.05B | $4.72B | $5.31B | $5.64B | $7.47B | $8.93B | $10.61B | $17.39B | $12.89B | $15.16B | $17.03B | $20.46B |
| QoQ Change | — | +12.8% | +7.9% | +7.0% | +8.1% | +32.6% | -27.3% | -19.5% | +14.7% | +59.0% | +16.7% | +12.5% | +6.1% | +32.4% | +19.6% | +18.8% | +64.0% | -25.9% | +17.6% | +12.4% | +20.1% |
| YoY Change | — | — | — | — | +40.6% | +65.3% | +11.4% | -16.1% | -11.0% | +6.8% | +71.4% | +139.5% | +121.6% | +84.6% | +89.1% | +99.7% | +208.5% | +72.6% | +69.8% | +60.6% | +17.6% |